Bortezomib will enhance the degree or outcome of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Enhanced flibanserin adverse consequences might occur if coadministered with a number of weak CYP3A4 inhibitors. Unlock 38% extra drug discovery time and eliminate conclusion-earning uncertainties using this one particular-end guidebook to excellent... https://yoda-109876.diowebhost.com/81836449/cp-866087-fundamentals-explained